Mangalam Drugs And Organics Limited — Others, 28-03-2025: Trading Window

Mangalam Drugs and Organics Limited has announced a board meeting on April 1, 2025, to declare the financial results for the quarter and half-year ended March 31, 2025. Consequently, the trading window for Designated Persons will remain closed starting April 1 until 48 hours post-announcement. This closure aims to prevent any insider trading ahead of the financial disclosure, ensuring compliance and transparency. Investors might view this as a necessary governance step, but it may create a temporary halt in trading activity, influencing short-term liquidity. Overall, the closure reflects the company's commitment to adhering to regulatory standards while preparing for a key financial update.